NCT05451849 2025-08-27A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerTCR2 TherapeuticsPhase 1/2 Active not recruiting6 enrolled
NCT04282044 2024-02-08Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid MalignanciesBioEclipse TherapeuticsPhase 1 Recruiting60 enrolled
NCT04025216 2024-01-24A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced CancersGilead SciencesPhase 1 Terminated16 enrolled
NCT05069935 2023-09-21FT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated16 enrolled